|
PIP4K2C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4584336222897E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0550005313803E-11 |
| Normal-vs-Stage2 |
3.14890002961477E-10 |
| Normal-vs-Stage3 |
1.27360000323762E-09 |
| Normal-vs-Stage4 |
1.27489999668384E-08 |
| Stage1-vs-Stage2 |
2.282600E-01 |
| Stage1-vs-Stage3 |
5.816600E-01 |
| Stage1-vs-Stage4 |
1.513600E-01 |
| Stage2-vs-Stage3 |
3.655000E-01 |
| Stage2-vs-Stage4 |
5.142400E-01 |
| Stage3-vs-Stage4 |
1.695770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62636570877339E-12 |
| Normal-vs-AfricanAmerican |
2.21129999977698E-07 |
| Normal-vs-Asian |
1.055740E-03 |
| Caucasian-vs-AfricanAmerican |
2.490600E-01 |
| Caucasian-vs-Asian |
6.040600E-01 |
| AfricanAmerican-vs-Asian |
9.652400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12054809875417E-12 |
| Normal-vs-Female |
2.20840012943313E-10 |
| Male-vs-Female |
3.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.13510378452997E-11 |
| Normal-vs-Extreme_Weight |
1.6251444634463E-12 |
| Normal-vs-Obese |
2.78987943858056E-12 |
| Normal-vs-Extreme_Obese |
2.513800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.185600E-01 |
| Normal_Weight-vs-Obese |
4.262800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.693400E-01 |
| Extreme_Weight-vs-Obese |
2.283000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.502800E-01 |
| Obese-vs-Extreme_Obese |
4.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.05880000000636E-05 |
| Normal-vs-Age(41-60Yrs) |
1.40559786032668E-11 |
| Normal-vs-Age(61-80Yrs) |
6.74682532064708E-13 |
| Normal-vs-Age(81-100Yrs) |
1.87030002596345E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.986440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.073800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.736300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.282400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.183700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.569400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62858615482264E-12 |
| Normal-VS-Type2 PRCC |
2.04020134120242E-11 |
| Normal-VS-KIRP CIMP |
5.89679999999371E-05 |
| Normal-VS-Unclassified PRCC |
1.98449999988526E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.390400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.378800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.865400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.765200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.510000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.874200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.50102152929321E-13 |
| Normal-vs-N1 |
1.01889999992721E-07 |
| Normal-vs-N2 |
2.377100E-03 |
| N0-vs-N1 |
2.650400E-01 |
| N0-vs-N2 |
5.104000E-01 |
| N1-vs-N2 |
9.292600E-01 |
|
|
